Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

S&P Biotech SPDR (NY: XBI )

100.67 +0.16 (+0.16%)
Streaming Delayed Price Updated: 3:20 PM EST, Nov 13, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about S&P Biotech SPDR

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Biotech Stocks Are Rallying: What Is Your Playbook?
If you have been reading our posts you know that some of the big biotech winners have taken a hit after earnings : LLY, MRK and REGN. But ABBV, GILD, LLY, and VRTX remain among the top performers. 
Via Talk Markets
Wednesday's Rally Followed By Friday's
Everyone who follows the stock market knows that a huge rally occurred on Wednesday, and by Friday, new highs were set for many of the most important stocks, ETFs, and Indexes. Tuesday's rally off the... 
Via Talk Markets
Topics ETFs
Smaller Cap Biotechs Are In Season: How Are We Doing?
SMID biotech stocks still see a lot of speculative interest except for a brief sell-off on August 5 when the XBI touched $91.The XBI is near its 2024 high in the $103 range. 
Via Talk Markets
Biotech Stocks Edge Higher. Could Trump 2.0 Mean More Innovation, Dealmaking?
Donald Trump won his second presidency in a victory over Kamala Harris. What can investors in biotech stocks expect? 
Via Investor's Business Daily
Topics Government
Exposures Political
Bearish Shooting Star Shines
Following signs of resistance in biotech ETF XBI on Friday, a shooting star forms. A bearish retracement may take hold soon.. 
Via Talk Markets
Topics ETFs
Volatility Hits Large Cap Biopharma: Active Rebalancing May Be Required
A bit of earnings and election jitters roiled the market last week reordering the leaderboard in biopharma stocks. 
Via Talk Markets
Biotech Momentum Trades For The Q4 Rally
The biotech sector made an interim peak in late February followed by an active summer in very choppy trading. 
Via Talk Markets
AskSlim Market Week - Friday, Oct. 25
An analysis and commentary on the financial markets. 
Via Talk Markets
Healthcare Sector Update: Choppy Days Are Here Again As Yields Rise
There has been a shift in healthcare stock performance by sub-sector which should be confirmed as we move through the Q3 earnings cycle. 
Via Talk Markets
Healthcare Sector Update: Life in the Slow Lane while we wait for BIOTECH Bounce
Healthcare sector lags despite moderate growth. Note bad news from CVS and Humana. 
Via Talk Markets
Stocks Drop On October 7, And Are Poised To Move Lower
The S&P 500 fell 90 bps today, closing at 5695, bringing the zero gamma level back into focus. This area has strong support, primarily because it separates the post-FOMC gap higher from the current... 
Via Talk Markets
Topics Stocks
Exposures US Equities
Biotech Stocks Poised For Another Big Move In Q4
The healthcare sector can be a safe haven if volatility increases. 
Via Talk Markets
Biotech Stocks : Are You A Trader Or A Longer Term Investor?
Biotech bull market is intact as indicated by large cap biopharma and the best performing funds. 
Via Talk Markets
BCYC: A Promising Play In The Biotech Sector
The long-awaited and overdue half-point cut in the federal funds rate was the impetus for the SPDR Biotech ETF to finally break above the 102-103 level. Meanwhile, Bicycle Therapeutics Plc. had a... 
Via Talk Markets
Topics ETFs
A Biotech Breakout Will Be Led By Small Caps
It’s hard to focus on biotech stocks right now because there are many distractions. The Fed and the rate cuts, AI and semiconductor stocks and geopolitical turmoil seemingly worse than ever. 
Via Talk Markets
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Interest Rates
Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
The Federal Reserve's recent 50bps rate cut could significantly boost biotech companies by lowering borrowing costs and improving access to capital. 
Via MarketBeat
Topics ETFs Economy
Exposures Economy Interest Rates
The Momentum Is Building, The Markets Are Strong - Just Don’t Chase After Extended Winners
Dozens of Top Ranked Magnet stocks breaking out 
Via Talk Markets
The Door Is Open, Time For The Fed To Act
With the CPI trending down and heading in the right direction, most economists are optimistic that the door is open for the Fed to lower rates. Economists, analysts, and investors are all waiting for... 
Via Talk Markets
Topics Economy
Exposures Interest Rates
Stocks Hit Pause As Economic Uncertainty Tempers The Rally
Stocks have been on a red-hot rally, but they’ve hit the brakes right at technical resistance, just as the charts predicted. 
Via Talk Markets
Biotech Life Science Trades: Small Caps Are Lagging But Poised For A Q4 Rally
Weaker than expected PPI up only 0.1% ignite rally with decline in services. Rate cuts imminent for September. 
Via Talk Markets
Healthcare Stocks Are Coming On Strong In July Led By Biotech
The biotech rally gained momentum in July with rotation out of technology stocks. 
Via Talk Markets
Life May Soon Get Easier for (Some) Biotech Stocks. Here's Why.
The Federal Reserve's fight against inflation may soon yield financial benefits. 
Via The Motley Fool
Topics Economy
Exposures Interest Rates
The Dow, The Russell, And The Biotech Sector Are Storming Higher
The Dow Jones Industrials have come up 4.2% over the latest five-day, while the Russell 2000 index of U.S. small-caps is up nearly 11% - it’s having its best week in 24 years. 
Via Talk Markets
Topics Stocks
Exposures US Equities
AskSlim Market Week - Friday, July 12
An analysis and commentary on the financial markets. 
Via Talk Markets
Stocks Are Breaking Down Beneath The Surface
Stocks and sectors are showing real signs of weakness despite the headline indexes going higher. 
Via Talk Markets
Healthcare Stocks Continue To Lag The Market-Can Anything Help ?
Healthcare stocks continue to lag the market up about 6% YTD, helped by Large Cap Biopharma but hurt by United Health. 
Via Talk Markets
Top Performing Industry ETFs In June: Software Leads Returns, Chipmakers Attract Most Inflows
June saw gains in the U.S. stock market, with tech and biotech leading the way. Semiconductor ETFs saw strong inflows, while utilities lagged. 
Via Benzinga
Topics ETFs
5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More
Biotech investing is risk-fraught but the returns could be staggering if one chooses to take the educated approach. 
Via Benzinga
Soft Inflation Data Boosts Small Caps, Real Estate, Regional Banks; Traders Anticipate Fed Rate Cuts As Stocks React
U.S. inflation slowed in May, boosting rate cut prospects. Markets rally ahead of FOMC meeting and assign 70% chance of rate cut in September. 
Via Benzinga
Topics Economy
Exposures Interest Rates
Healthcare And Biotech Investing: Breakthroughs In The Treatment Of Cancer At ASCO
Healthcare stocks underperformed YTD because of weakness in UNH and strength in Technology and Communication Services. 
Via Talk Markets
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.